exagamglogene autotemcel for severe sickle cell disease
Published 6 months ago • 306 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
1:43
approval of exa-cel for scd
-
1:53
sickle cell disease: an overview and future therapies
-
1:43
the role of complement activation in complications of sickle cell disease
-
0:54
climb thal-111: exagamglogene autotemcel for patients with β-thalassemia
-
7:37
crispr's next advance is bigger than you think | jennifer doudna | ted
-
3:51
sickle cell disease | moa animation
-
43:42
easl studio - s2 e17 - easl haemochromatosis guidelines 2022
-
1:26
improving outcomes in sickle cell disease: expanding access and expediting treatment development
-
13:54
exagamglogene autotemcel for bthal and scd
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl
-
3:02
euplagia-1: phase i trial of glpg5201, a cd19 car-t product, in r/r cll and richter's transformation
-
2:05
cell salvage and hemodilution
-
0:51
changes in physical, mental, and social health of adults with scd following allosct
-
1:04
the future of cll therapy
-
3:59
3-year follow-up from the transform trial: liso-cel is superior to soc in r/r dlbcl
-
2:45
the value of axi-cel as a second-line treatment in r/r lbcl
-
1:03
insights into the cartitude-6 trial: rationale and design
-
1:59
prospective study evaluating complement activation in patients with sickle cell disease
-
8:57
outcomes of sct in t-all and t-lbl
-
0:38
the functional role of cd4- and cd8-expressing t-cells in aml